No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:180275400-180276000 |
Bivalent Enhancer |
Primary B cells from peripheral blood |
blood
|
2 |
chr2:180275400-180276000 |
Enhancers |
Primary T cells fromperipheralblood |
blood
|
3 |
chr2:180275400-180276000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
4 |
chr2:180275600-180276000 |
Enhancers |
Adipose Nuclei |
Adipose
|
5 |
chr2:180275600-180277200 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
6 |
chr2:180275800-180276000 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
7 |
chr2:180275800-180276000 |
Flanking Active TSS |
Brain Dorsolateral Prefrontal Cortex |
brain
|
8 |
chr2:180275800-180276000 |
Flanking Active TSS |
Brain Substantia Nigra |
brain
|
9 |
chr2:180275800-180276000 |
Enhancers |
Fetal Muscle Leg |
muscle
|
10 |
chr2:180275800-180276200 |
Enhancers |
Brain Angular Gyrus |
brain
|
11 |
chr2:180275800-180276200 |
Flanking Active TSS |
Brain Anterior Caudate |
brain
|
12 |
chr2:180275800-180276200 |
Active TSS |
Brain Hippocampus Middle |
brain
|
13 |
chr2:180275800-180276200 |
Flanking Active TSS |
Brain Inferior Temporal Lobe |
brain
|
14 |
chr2:180275800-180276200 |
Flanking Bivalent TSS/Enh |
HepG2 |
liver
|
15 |
chr2:180275800-180277000 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
16 |
chr2:180275800-180277400 |
Enhancers |
ES-I3 Cell Line |
embryonic stem cell
|
17 |
chr2:180275800-180277400 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
18 |
chr2:180275800-180277400 |
Enhancers |
Osteobl |
bone
|